Sen. Hillary Clinton at the 2007 Take Back America Conference promised to lift the ban on embryonic stem cell research.
According to the NIH:
In 2000, the Clinton Administration published guidelines governing the use of human embryonic stem cells in the Federal Register on August 23, 2000.
On April 25, 2001, a scheduled review of pending grant applications was postponed to provide President George W. Bush and his new Administration an opportunity to review the issue.
On August 9, 2001, President Bush issued a long-awaited decision on stem cell research. He authorized funding of stem cell research using existing pluripotent stem cell lines that were derived from human embryos before August 9. Such research is eligible for Federal funding if the following criteria are met:
1) there must have been informed consent of the donors,
2) the embryos must have been created for reproductive purposes and in excess of clinical need,
3) there must not have been any financial inducements to the donors, and
4) the embryos must not have been created for research purposes.
During fiscal year (FY) 2002, the National Institutes of Health (NIH) funded the first grants to conduct human embryonic stem cell research, including both new grants and supplements to existing grants.
In the fall of 2007, Hillary told the Carnegie Institute, “The Bush administration has declared war on science. When I am president, scientific integrity will not be the exception it will be the rule.”
Then, Senator Clinton said she was “committed” to seeing that stem cell research moves forward. She voted in favor of the Stem Cell Research Enhancement Act, and has also worked to expand the budget of the National Institutes of Health.
In 2014, the San-Diego Union reported that Hillary Clinton was advocating for Biotech companies especially those in California:
“California (undertook) a very important task in creating a funding stream for stem cell research,” Clinton said. “Other states have followed suit, when it looked as though the federal government would not be doing that. States have a role to play, but we need a national framework.”
Clinton was referring to the California Institute for Regenerative Medicine, funded with $3 billion in bond money. The program was created in 2004 by California voters in part because former president George W. Bush, the first president to fund embryonic stem cell research, limited funding to those lines of human embryonic stem cells created by August, 2001. CIRM and the federal government also fund research with many other types of non-embryonic stem cells.
On June 25, 2014, Hillary Clinton was interviewed by Jim Greenwood, president and CEO of the Biotechnology Industry Organization, at their San Diego Convention Center pushing fetal research and GMO’s.
“I don’t want to see biotech companies or pharma companies moving out of our country simply because of some perceived tax disadvantage and potential tax advantage somewhere else,” she said.
“If Washington is not welcoming to this kind of effort, maybe it could be put together by the states that are the leaders in hosting biotech companies,” she said, citing California funding stem cell research when the federal government would not.
She also supported the promotion of GMO or genetically modified seeds which she labels “drought resistant.”
Recently, Hillary Rodham Clinton defended abortion biz Planned Parenthood who sells aborted baby parts to Biotech firms for medical research.